Lavipharm S.A. logo

Lavipharm S.A. (LAVI)

Market Closed
12 Aug, 14:20
ASE ASE
1. 57
+0
+0.2554%
142.35M Market Cap
- P/E Ratio
- Div Yield
9,742 Volume
0 Eps
1.57
Previous Close
Add Transaction
Day Range
1.56 1.58
Year Range
0.76 1.74
Want to track LAVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LAVI closed today higher at €1.57, an increase of 0.2554% from yesterday's close, completing a monthly increase of 1.8158% or €0.03. Over the past 12 months, LAVI stock gained 60.2041%.
LAVI pays dividends to its shareholders, with the most recent payment made on Jul 24, 2026. The next estimated payment will be in In 11 months on Jul 24, 2027 for a total of €0.02.
Lavipharm S.A. has completed 8 stock splits, with the recent split occurring on Nov 28, 2022.
The company's stock is traded on one exchange.

LAVI Chart

People also search for

Austriacard Holdings AG
9.83
+0.1018%
Fourlis S.A.
4.05
-0.3686%
N. Varveris - Moda Bagno S.A.
7.1
+1.4286%
Daios Plastics S.A.
8
0%

Lavipharm S.A. (LAVI) FAQ

What is the stock price today?

The current price is €1.57.

On which exchange is it traded?

Lavipharm S.A. is listed on ASE.

What is its stock symbol?

The ticker symbol is LAVI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 142.35M.

Has Lavipharm S.A. ever had a stock split?

Lavipharm S.A. had 8 splits and the recent split was on Nov 28, 2022.

Lavipharm S.A. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Vassilis Baloumis CEO
ASE Exchange
GRS246073001 ISIN
DE Country
300 Employees
20 Jul 2026 Last Dividend
28 Nov 2022 Last Split
- IPO Date

Overview

Lavipharm S.A., founded in 1911 and headquartered in Paiania, Greece, is an esteemed entity in the global healthcare industry, focusing on the research, development, manufacture, import, marketing, sale, and wholesale of a broad spectrum of pharmaceutical, dermocosmetic, and healthcare products. Catering to both the Greek market and an international clientele, the company has established itself as a key player in providing healthcare solutions directly to physicians and pharmacists. With a rich legacy spanning over a century, Lavipharm S.A. combines its profound experience with innovative practices to bring effective healthcare solutions to the forefront of the industry.

Products and Services

  • Pharmaceutical Products for Specialized Fields
  • Lavipharm S.A. offers a diverse portfolio of pharmaceutical products targeting various critical areas of healthcare such as cardiology, oncology-urology, the central nervous system, and chronic pain management. This encompasses a range of medications designed to meet the therapeutic needs of patients, ensuring efficacy and safety across these core medical specialties.

  • Self-treatment Solutions
  • Understanding the growing trend towards self-care, the company provides a selection of products aimed at self-treatment. These are designed to empower individuals to manage their health proactively, with over-the-counter (OTC) options that are both accessible and reliable, fostering a culture of wellness and preventive care.

  • Prescription Medicines
  • Key to its product lineup, Lavipharm S.A. markets a variety of prescription medicines. These pharmaceuticals are developed based on rigorous research and adherence to industry standards, ensuring that healthcare professionals and patients have access to effective treatment options for a multitude of health concerns.

  • Over-the-Counter (OTC) Products
  • The range of over-the-counter (OTC) products offered by Lavipharm S.A. includes a vast selection of medications and health aids that can be purchased without a prescription. This segment enables consumers to address common health issues promptly and conveniently, enhancing the general wellbeing of the community.

  • LIFELAB CBD
  • Embracing the therapeutic potentials of cannabidiol (CBD), Lavipharm S.A. has ventured into the provision of LIFELAB CBD products. This line represents the company’s commitment to innovation in healthcare, offering scientifically-backed, CBD-infused solutions designed to support a range of health and wellness needs.

Contact Information

Address: 12, Agias Marinas Street, Paiania, Greece, 190 02
Phone: 30 210 66 91 000